BLLN today
$113.79+$1.79 (+1.60%)close Nov 11, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bullish
1 hourSymmetric Triangle
15 minBullish
5 minStrong Bullish
Daily trend turns up above $150.44
Key levels
Resistance$133.66
Resistance$123.85
Support$113.00
Support$102.00
Latest news & SEC filings
SEC FilingBillionToOne, Inc. filed an insider trading report (Form 4)
AnalystPiper Sandler keeps Overweight on BillionToOne, cuts price target to $130
All BLLN news →About BillionToOne
BillionToOne is a molecular diagnostics company that develops blood-based tests for prenatal and oncology care. Its UNITY line of prenatal tests assesses fetal risk for inherited conditions, chromosomal abnormalities, and certain blood group markers from a maternal blood sample. Its Northstar liquid biopsy tests help physicians choose treatments and track how patients respond to cancer therapy. The company sells to physicians, hospitals, and clinical laboratories, primarily in the United States.
Based on the company's 10-K filed Mar 11, 2026.
Nasdaq · Healthcare
BillionToOne, Inc. (BLLN)
What Is the Price Target for BLLN?
SEPT Low Target
$107.52
SEPT Mid Target
$126.50
SEPT High Target
$145.47
Analyst Consensus
$126.50
Is BLLN a Buy or Sell Right Now?
Thesis
- •Revenue growing 100.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BLLN.
Start Free Trial →Is BLLN Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$104.19
55
Moat Score
NARROW
7/9
Piotroski Score
9.8
Altman Z-Score
What Is Smart Money Doing with BLLN?
Insider Signal
SELLING
0 buys / 12 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Ileri Firat | director 10% owner | Sale | 436 | $50K | Nov 6, 2026 |
| Atay Oguzhan | director officer | Buy | 16,667 | $47K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Buy | 8,334 | $23K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Sale | 1,482 | $159K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Sale | 4,009 | $434K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Sale | 5,720 | $624K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Sale | 3,803 | $419K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Sale | 1,117 | $124K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Sale | 536 | $60K | Nov 2, 2026 |
| Atay Oguzhan | director officer | Sale | 974 | $105K | Nov 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BLLN Growth Story
Revenue YoY
100.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
103.4%
FCF Growth YoY
133.6%
Revenue Trend
STRONG
Dark Pool Trades for BLLN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BLLN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:22:30 | $114.05 | 1,000 | $$114K | BUY |
| 16:22:27 | $113.62 | 1,000 | $$114K | SELL |
| 16:20:43 | $113.75 | 1,000 | $$114K | BUY |
| 16:20:41 | $113.58 | 1,000 | $$114K | SELL |
| 16:20:39 | $113.58 | 1,000 | $$114K | SELL |
5 dark pool trades shown · $$569K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BillionToOne, Inc. (BLLN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BLLN — frequently asked questions
What is BLLN stock price today?
BillionToOne, Inc. (BLLN) is at $113.79, up 1.60% (+$1.79) at the Nov 11, 2026 close.
Why is BLLN stock moving today?
Latest BLLN news — Nov 10, 2026: BillionToOne, Inc. filed an insider trading report (Form 4) · Nov 10, 2026: Piper Sandler keeps Overweight on BillionToOne, cuts price target to $130
What is the BLLN price target?
The average analyst price target for BLLN is $126.50, ranging from $120 to $130, based on 4 analysts. Latest: Guggenheim maintains on Oct 1, 2026.
What do analysts rate BLLN?
Analyst ratings for BLLN: 2 Buy, 5 Hold, 0 Sell — consensus Hold.
Did BLLN beat earnings?
BLLN last reported on Aug 5, 2026: EPS $0.15 vs $0.18 expected — a miss of 18.2%.
What is BLLN's P/E ratio?
BLLN trades at a P/E of 756.4.
How much debt does BLLN have?
BillionToOne, Inc. reported $91M of debt and $549M of cash (Jun 30, 2026).
What are BLLN support and resistance levels?
Support: $113.00, $102.00, $90.48. Resistance: $123.85, $133.66, $150.44.
What are insiders doing with BLLN?
Insider activity: SELLING, 0 buys and 12 sells in the last 90 days.
What is the latest news on BLLN?
Nov 10, 2026: BillionToOne, Inc. filed an insider trading report (Form 4) · Nov 10, 2026: Piper Sandler keeps Overweight on BillionToOne, cuts price target to $130